Clinical Trial: Evaluation of the efficacy and safety of photobiomodulation therapy in patients with mild cognitive impairment and mild Alzheimer's disease: a 6-month, single-center, randomized, double-blind, controlled trial (China)

China, Nov. 3 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Evaluation of the efficacy and safety of photobiomodulation therapy in patients with mild cognitive impairment and mild Alzheimer's disease: a 6-month, single-center, randomized, double-blind, controlled trial'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600135757

Registration Time: 2026/11/02

Type: Interventional study

Primary Sponsor: Beijing Tiantan Hospital Affiliated to Capital Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=214800

Published by HT Digital Content Services with permission from Health Daily Digest....